Parkinson’s disease is the second most common incurable neurodegenerative disorder after Alzheimer’s disease.
It is characterised by the accumulation of protein deposits in dopaminergic neurons (in charge of producing dopamine) in the form of amyloid fibres. These aggregates are formed mainly by the alpha-synuclein protein and in a very complex manner, which makes it complicated to identify molecules which could prevent or revert the process and the neurodegeneration associated with it.
A scientific collaboration led by researchers at the Institute of Biotechnology and Biomedicine (IBB) of the Universitat Autònoma de Barcelona has identified a molecule which halts and reverts this neurodegeneration. After analysing over 14,000 molecules, they found the SynuClean-D molecule, which inhibits the aggregation of the alpha-synuclein protein and breaks the already formed amyloid fibres, thus preventing the initiation of the process causing the onset of the neurodegenerative Parkinson’s disease.
Through experiments conducted with the small Caenorhabditis elegans worm, one of the most commonly used animal models in neurodegenerative diseases, researchers were able to verify that by administering it through food, the molecule was capable of notably reducing alpha-synuclein aggregations, preventing the spread of toxic aggregates and therefore avoiding the degeneration of dopaminergic neurons.
“Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative disases such as Parkinson’s in the future”, UAB researcher and coordinator of the study Salvador Ventura points out.
To identify SynuClean-D researchers developed a methodology capable of indentifying the alpha-synuclein aggregation inhibitors among thousands of molecules. Once identified, an in vitro biophysical characterisation was conducted of their inhibiting activity and tests were run to discover their behaviour with human neural cell cultures, before testing it in animal models of the disease (the Caenorhabditis elegans worm). These animals express the alpha-synuclein in the muscle or in dopaminergic neurons. The experiments demonstrated that the administration of the identified inhibitor reduced protein aggregation, improving the mobility of the animal and protecting it from neural degeneration.
Learn more: Molecule capable of halting and reverting neurodegeneration caused by Parkinson’s disease identified
The Latest on: Parkinson’s
[google_news title=”” keyword=”Parkinson’s” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Parkinson’s
- Physical exercise can improve movement-related symptoms and quality of life in Parkinson'son March 22, 2023 at 8:46 pm
In a recent review published in the Cochrane Database of Systematic Reviews, researchers in Germany performed a network meta-analysis (NMA) to evaluate the effectiveness of physical exercise in ...
- US FDA declines to approve AbbVie's Parkinson's disease therapyon March 22, 2023 at 3:40 pm
AbbVie Inc said on Wednesday the U.S. Food and Drug Administration had declined to approve its Parkinson's disease therapy for adults and had requested for more information on the device used to ...
- Radio 1Xtra's Reece Parkinson quits DJ role and reveals surprising career changeon March 22, 2023 at 2:28 pm
BBC Radio 1Xtra presenter Reece Parkinson is ditching the airwaves for the world of science. He announced his imminent exit and surprising career switch in a tweet thread earlier this week, which ...
- CT Parkinson's Symposium Sparks Hope for Andover Woman Battling the Diseaseon March 22, 2023 at 1:53 pm
Nearly one million people in the United States are living with Parkinson’s disease, according to the Parkinson’s Foundation. The 2023 Connecticut Parkinson’s Symposium will bring some of them together ...
- Exercise Does Help People With Parkinson's Disease, Review Findson March 22, 2023 at 11:00 am
Exercise can help improve movement-related symptoms for people who have Parkinson’s disease, a new review finds.
- Exercise may improve movement for people with Parkinson's diseaseon March 22, 2023 at 7:22 am
Exercise can help improve movement-related symptoms for people who have Parkinson's disease, a new review finds. And any type of structured exercise is better than none, researchers added. The ...
- Is Parkinson’s disease, 'world’s fastest growing brain disease,’ mostly preventable? Study offers clueson March 22, 2023 at 5:09 am
New research published in the Journal of Parkinson's disease suggests the harmful effects of a colorless chemical, trichloroethylene (TCE), may be linked to Parkinson's; more work is needed.
- Common Chemical Linked to Parkinson’s Diseaseon March 21, 2023 at 3:10 pm
According to a new paper by an international team of scientists, the chemical known as TCE may be associated with as much as a 500% increased risk for Parkinson’s disease.
- Parkinson's Research Newson March 20, 2023 at 5:00 pm
Jan. 10, 2023 — New research says the gut microbiome is involved in multiple pathways in the pathogenesis of Parkinson's disease. The findings show a wide imbalance in microbiome composition in ...
via Bing News